Novo Nordisk GLP-1 liraglutide may slow Alzheimer’s progression

Novo Nordisk GLP-1 liraglutide may slow Alzheimer’s progression

A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020.

George Frey | Reuters

An older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer’s disease by…

[ad_2]

Source link

More From Author

Blast stubborn belly fat and support muscle growth with 'creamy' 79p product

Blast stubborn belly fat and support muscle growth with 'creamy' 79p product

How to exercise in a heatwave: We ask the experts for tips on working out safely

How to exercise in a heatwave: We ask the experts for tips on working out safely

Leave a Reply

Your email address will not be published. Required fields are marked *